Acneiform Drug Eruption clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway
Sorry, not yet accepting patients
A phase 2 study testing the efficacy of isotretinoin versus doxycycline in treating participants who develop a acneiform rash caused by standard of care, tumor-directed therapies targeting the mitogenactivated protein kinase (MAPK) pathway.
at UCSF
Our lead scientists for Acneiform Drug Eruption research studies include Sabine Mueller, MD, PhD, MAS.
Last updated: